×

注意!页面内容来自https://www.arthritis.org/science/osteoarthritis/karat-clinical-trial,本站不储存任何内容,为了更好的阅读体验进行在线解析,若有广告出现,请及时反馈。若您觉得侵犯了您的利益,请通知我们进行删除,然后访问 原网页

skip to main content

ES

KArAT Clinical Trial

KArAT (Knee Arthroplasty Activity Trial) is a largemulti-site study testing whether one-on-one support from a health coach and small financial rewards can help people become more physically active after total knee replacement surgery. 

<> .longformatV2 .longformat-content h1 { font-size: 3rem; } .longformatV2 .longformat-content h2 { font-size: 2.25rem; } .longformatV2 .longformat-content h3 { font-size: 1.875rem; } .longformatV2 .longformat-content h4 { font-size: 1.25rem; } .longformatV2 .longformat-content h5 { font-size: 1.125rem; } .longformatV2 .longformat-content h6 { font-size: 1rem; }

Trial Overview

Each yearover 750,000 Americans undergo total knee replacement (TKR) to relieve pain and restore function caused by advanced osteoarthritis. While surgery is highly effective at reducing pain and improving functionstudies show that up to 80% of patients do not increase their physical activity levels after recoverymissing a critical opportunity to improve long-term health outcomesincluding cardiovascular fitness and weight management. To address this gapthe Arthritis Foundation and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) are supporting the KArAT interventional trial. This innovative study will test whether personalized health coaching and financial incentives can help patients get moving — and stay moving — after TKR.
<> .longformatV2 .longformat-content h1 { font-size: 3rem; } .longformatV2 .longformat-content h2 { font-size: 2.25rem; } .longformatV2 .longformat-content h3 { font-size: 1.875rem; } .longformatV2 .longformat-content h4 { font-size: 1.25rem; } .longformatV2 .longformat-content h5 { font-size: 1.125rem; } .longformatV2 .longformat-content h6 { font-size: 1rem; }
trial participants: 600trial condition: osteoarthritistrial age range: 40-85trial length: 2 years
KArAT at a Glance

What type of study is the KArAT trial?

KArAT is a randomized controlled trial focused on behavior change. It tests whether personalized health coaching and small financial rewards can help people become more physically active after total knee replacement surgerysupporting recovery and long-term health.

How does the KArAT trial use health coaching to support recovery after knee replacement?

In the KArAT trialpatients may receive regular phone calls from a health coach starting about six weeks after surgery. The coach helps them set step goalsoffers encouragement and talks through challenges. This supportalong with activity tracking and small rewardsis designed to help patients stay active during recovery.

What happens when a patient is enrolled?

When a patient enrolls in the KArAT trialthey complete baseline surveys and wear an activity monitor for one week before knee replacement surgery. After surgerythey are randomly assigned to one of three groups: usual careusual care with a Fitbit trackeror usual care with a Fitbitpersonalized health coaching plus financial rewards. Participants are monitored for two years through periodic surveysactivity tracking and scheduled check-in calls. Those in the coaching group receive weekly or biweekly phone sessions and can earn financial incentives for meeting physical activity goals.

Are there risks associated with the study?

The KArAT study uses low-risk interventionsincluding remote health coachingwearable activity trackers and financial incentives. These components are generally safewith only minor issues like skin irritation or mild musculoskeletal strain reported in similar studies. Participants are monitored to ensure safety throughout the trial.

<> .longformatV2 .longformat-content h1 { font-size: 3rem; } .longformatV2 .longformat-content h2 { font-size: 2.25rem; } .longformatV2 .longformat-content h3 { font-size: 1.875rem; } .longformatV2 .longformat-content h4 { font-size: 1.25rem; } .longformatV2 .longformat-content h5 { font-size: 1.125rem; } .longformatV2 .longformat-content h6 { font-size: 1rem; }
For Providers:
National Clinical Trial No. for the KArAT clinical trial
NCT04107649

For more information about the KArAT trialvisit ClinicalTrials.gov.

Abby Smith Helps Knee Patients Set Goals for Recovery

Research assistant sees motivational coaching after knee replacement making a real difference. 

Read Article

Researcher Brings Decades of Experience to Osteoarthritis Trial

Dr. Jeffrey Katz mentors other investigators and helps guide clinical decisions in this Arthritis Foundation-supported knee OA study. 

Read Article

Neil Segal’s Multi-Faceted Career Focuses on Arthritis

His interests come together in this trial to help people become more active after a knee replacement.

Read Article

Math and Medicine Just Adds Up for Elena LosinaPhD

This principal investigator leads several Arthritis Foundation-funded studies in preventing osteoarthritis. 

Read Article

Annie Nolan Helps Trial Participants Increase Activity

Research assistant puts her interest in improving quality of life to work in the KArAt Clinical Trial.

Read Article
Rationale & Design
KArAT Trial

Rationale & Design

This manuscript outlines the rationalestudy design and implementation of the KArAT trialwhich is exploring incentives to increase activity after total knee arthroscopy.

Read Manuscript
Scientific Publications

KArAT Presentation

Elena LosinaPhDlead principal investigator of the Knee Arthroplasty Activity Trial (KArAT) clinical trial and a professor of orthopedic surgery at Brigham and Women's Hospitalshares a technical overview of the KArAT trial and its progress. Check back for updates.

See the Presentation
KArAT Presentation
<> .longformatV2 .longformat-content h1 { font-size: 3rem; } .longformatV2 .longformat-content h2 { font-size: 2.25rem; } .longformatV2 .longformat-content h3 { font-size: 1.875rem; } .longformatV2 .longformat-content h4 { font-size: 1.25rem; } .longformatV2 .longformat-content h5 { font-size: 1.125rem; } .longformatV2 .longformat-content h6 { font-size: 1rem; }

Clinical Trial Sites

  • Brigham and Women's HospitalBostonMA
    • Principal Investigator: Elena LosinaPhDMSc
  • Northwestern Memorial HospitalChicagoIL 
    • Site Principal Investigator: Rowland ChangMDMPH
  • University of Kansas Medical CenterKansas CityKS
    • Site Principal Investigator: Neil SegalMD
  • University of Nebraska Medical CenterOmahaNEand ColumbusOH
    • Site Principal Investigator: Elizabeth WellsandtPTDPTPhD
  • University at BuffaloBuffaloNY
    • Site Principal Investigator: Scott R. NodzoMD

Osteoarthritis Research Program

The Arthritis Foundation’s osteoarthritis (OA) program aims to accelerate the development of effectiveevidence-based solutions to improve outcomes for people living with OA.

Read More

PIKASO Clinical Trial

PIKASO is a collaborativerandomized clinical trial testing whether metformin can slow or prevent osteoarthritis progression in people with major knee injuries.

Get the Study Details

TOPS Clinical Trial

The TOPS clinical trial tests if diet and exercise can help women over 50 reduce their risk of knee osteoarthritis.

Learn More
<> .mobile-image { display: none; } .desktop-image { display: block; } @media(max - width: 768px) { .desktop-image { display: none; } .mobile-image { display: block; } } :root { --engage-color: #00AD50 ; }
Engagement Widget

Stay in the Know. Live in the Yes.

Get involved with the arthritis community. Tell us a little about yourself andbased on your interestsyou’ll receive emails packed with the latest information and resources to live your best life and connect with others.